MedTrace Logo

Pilot Study of Internet-Delivered Psychological Treatment for Cancer Survivors

NCT06046573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-12-16

No results posted yet for this study

Summary

Negative psychological effects of cancer are common, but cancer survivors are rarely offered structured psychological treatment. Internet-delivered treatments have shown some promise, but specific treatment components have not been empirically evaluated which means that it is not clear which therapies that should be prioritized. In this factorial pilot study, 48 cancer survivors with psychiatric symptoms are enrolled in variations on a 10-week therapist-guided online psychological treatment intended to address common negative psychological long-term effects of cancer. The aim of this study is to assess the feasibility of the study design and online treatment format. Key feasibility outcomes include interest in the study, patient-reported credibility of the intervention, adherence to the treatment protocol, satisfaction with the treatment, acceptability of the measurement strategy, missing data rates, adverse events, and preliminary efficacy on anxiety, depression, the fear of recurrence, and health-related quality of life.

Conditions

Interventions

BEHAVIORAL

Support and information

Emotional and technical support. Information about the long-term effects of cancer.

BEHAVIORAL

Behavioral activation

Behavioral activation with existential themes and emphasis on values and relationships.

BEHAVIORAL

Systematic exposure with mindfulness training

Systematic exposure with mindfulness training with a focus on anxiety about health and/or death, body image, and cancer-related trauma.

BEHAVIORAL

Promotion of health behaviors

An overview of self-management techniques in terms of physical exercise, dietary advice, and strategies for improved sleep.

Sponsors & Collaborators

Principal Investigators

  • Erland Axelsson, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-10
Primary Completion
2024-10-22
Completion
2024-10-22

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06046573 on ClinicalTrials.gov